A survey of the management of breast cancer in England and Wales

Annals of the Royal College of Surgeons of England

Volumn 78, Issue 3 Part I, 1996, Pages 197-202

  Harries, S A ^a,c   Lawrence, R N ^a   Scrivener, R ^a   Fieldman, N R ^a   Kissin, M W ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Audit; Breast cancer; Surgical treatment

Indexed keywords

TAMOXIFEN;

ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; COMPARATIVE STUDY; FOLLOW UP; HUMAN; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; QUESTIONNAIRE; SEGMENTAL MASTECTOMY; SENESCENCE; SURGEON; TUMOR RECURRENCE; UNITED KINGDOM;

AGE FACTORS; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY, NEEDLE; BREAST NEOPLASMS; ENGLAND; FEMALE; HUMANS; LONG-TERM CARE; LYMPHATIC METASTASIS; MASTECTOMY; MEDICAL AUDIT; NEOPLASM RECURRENCE, LOCAL; PROFESSIONAL PRACTICE; WALES;

EID: 9344227847     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Chamberlain J. Epidemiology of breast cancer. In: Bum I, Bloom HJG, eds. Breast Cancer (U.I.C.C.) Springer-Verlag, 1989.
2. McCarthy M, Bore J. Treatment of breast cancer in two teaching hospitals: a comparison with consensus guidelines. Eur J Cancer 1991; 27: 579-82.
3. Chouillet A, Bell CM, Hiscox JG. A survey of the management of breast cancer in Southeast Engand. Br Med J 1994; 308: 168-71.
4. Atkins H, Hayward J, Klugman D et al. Treatment of early breast cancer: a report after 10 years of a clinical trial. Br Med J 1972; 2: 423-9.
5. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection on level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992; 28A: 1415-18.
6. Bates T. Tamoxifen treatment for breast cancer in elderly patients. Br J Surg 1992; 79: 454 (Abstract).
7. Sainsbury R, Haward B, Rider L et al. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1256-70.
8. Basnett I, Gill M, Tobias JS. The management of breast cancer in a teaching and a non-teaching district. Ear J Cancer 1992; 28A: 1945-50.
9. Veronesi U, Saccozzi R, Del Vecchio M et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981; 305: 6-11.
10. Fisher B, Bauer M, Margolese R et al. Five-year results of a randomised clinical trial comparing total mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665-73.
11. Gazet JC, Rainsbury RM, Ford HT, Powles TJ, Coombes RC. Survey of treatment of primary breast cancer in Great Britain. Br Med J 1985; 290: 1793-5.
12. Morris J, Royle GT, Taylor I. Changes in the surgical management of early breast cancer in England. J R Soc Med 1989; 82: 12-14.
13. 1/2 breast cancer in England. Eur J Cancer 1992; 28A: 1709-12.
14. The Medical Directory. Longman Group UK Ltd, 1992.
15. Fentiman IS, Mansel RE. The axilla: not a no go zone. Lancet 1991; 337: 221-3.
16. O'Dwyer PJ. Axillary dissection in primary breast cancer. Br Med J 1991; 302: 360-61.
17. Early Breast Cancer Trialists Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrence and 24 000 deaths among 75 000 women. Lancet 1992; 339: 1-15, 71-85.
18. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16: 127-33.
19. Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomised trial. Br J Surg 1985; 72: 368-9.
20. Sacks NP, Barr LQ Allan SM, Baum M. The role of axillary dissection in operable breast cancer. The Breast 1992; 1:41-9.
21. Preece PE, Wood RAB, Mackie CR, Cushieri A. Tamoxifen as the sole treatment for localised breast cancer in elderly women. Br Med J 1982; 284: 869-70.
22. Dixon JM. Treatment of elderly patients with breast cancer. Br Med J 1992; 304: 996-7.
23. Locker AP, Ellis IO, Morgan DAL, Elston CW, Mitchell A, Blarney RW. Factors affecting local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989; 76: 890-4.
24. Dixon. JM. Br Med J 1992; 305: 114 (letter).
25. Morris S, Corder AP, Taylor I. Breast cancer follow up: why do we do it? Eur J Surg Oncol 1992; 18: 408-9.
26. Zwaveling A, Albers GHR, Felthius W, Hermans J. An evaluation of routine follow-up for detection of breast cancer recurrence. J Surg Oncol 1987; 34: 194-7.
27. Young J. Incidence and mortality of breast cancer. In: Kennedy B, ed. Breast Cancer. New York: Alan Liss, 1989: 1-5.
28. Rutgers EJ, van-Slooten EA, Kluck HM. Follow-up after treatment of primary breast cancer. Br J Surg 1989; 76: 187-90.